These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 1479226)

  • 1. [Visceral fat syndrome].
    Tokunaga K; Nakamura T; Kubo M; Matsuzawa Y
    Nihon Naika Gakkai Zasshi; 1992 Nov; 81(11):1831-5. PubMed ID: 1479226
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hyperlipidemia complicated with hypertension].
    Takagi S; Shimamoto K
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():738-42. PubMed ID: 11347164
    [No Abstract]   [Full Text] [Related]  

  • 3. [Insulin resistance and hyperinsulinemia--clinical aspects].
    Kozek E
    Przegl Lek; 1996; 53(9):647-52. PubMed ID: 8992530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertension, hyperlipidemia, insulin resistance and obesity: parts of a metabolic syndrome.
    Lind L; Lithell H
    Blood Press Suppl; 1992; 4():49-54. PubMed ID: 1345335
    [No Abstract]   [Full Text] [Related]  

  • 5. [Coronary risk factors. Anatomoclinical study].
    Degeratu T; Nicolaescu V; Nuţă M; Cîmpeanu A; Cucu N
    Med Interna (Bucur); 1974 Jan; 26(1):61-72. PubMed ID: 4821152
    [No Abstract]   [Full Text] [Related]  

  • 6. [Primary and secondary prevention of coronary heart disease. A position paper of the International Task Force for the Prevention of Coronary Heart Disease].
    Cullen P; Assmann G
    Dtsch Med Wochenschr; 2000 Jul; 125(28-29):881-7. PubMed ID: 10943220
    [No Abstract]   [Full Text] [Related]  

  • 7. [Significance of visceral fat syndrome in pathogenesis of impaired glucose tolerance].
    Nakamura T
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():246-9. PubMed ID: 15779380
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevention of heart disease in the young coronary candidate.
    Kannel WB
    Prim Care; 1977 Jun; 4(2):229-43. PubMed ID: 586715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial type IV hyperlipoproteinemia.
    Schreibman PH; Wilson DE; Arky RA
    N Engl J Med; 1969 Oct; 281(18):981-5. PubMed ID: 5824739
    [No Abstract]   [Full Text] [Related]  

  • 10. [Obesity and insulin resistance syndrome].
    Tokunaga K; Matsuzawa Y
    Nihon Rinsho; 1996 Oct; 54(10):2679-86. PubMed ID: 8914427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of obesity in primary hyperlipidemias.
    Carmena R; Ascaso JF; Real JT
    Nutr Metab Cardiovasc Dis; 2001 Oct; 11(5):354-9. PubMed ID: 11887432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lipids and arteriosclerosis].
    Carmena R
    Rev Clin Esp; 1973 Aug; 130(3):181-94. PubMed ID: 4201566
    [No Abstract]   [Full Text] [Related]  

  • 13. Dietary carbohydrates in lipid disorders in man.
    Albrink MJ
    Prog Biochem Pharmacol; 1973; 8():242-70. PubMed ID: 4597900
    [No Abstract]   [Full Text] [Related]  

  • 14. [Diagnostic criteria of insulin resistance and multiple risk factor syndrome].
    Hashimoto N; Saito Y
    Nihon Rinsho; 2000 Feb; 58(2):405-10. PubMed ID: 10707566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lipoprotein abnormality in obesity].
    Kawakubo K; Lee JS
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():137-42. PubMed ID: 11347046
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevention of coronary heart disease: a nonhormonal approach.
    Lewis V; Hoeger K
    Semin Reprod Med; 2005 May; 23(2):157-66. PubMed ID: 15852201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical implications of insulin resistance.
    Peters AL
    Am J Manag Care; 2000 Aug; 6(13 Suppl):S668-74; discussion S675-81. PubMed ID: 11183420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Artherosclerotic ischemic coronary disease. Etiopathogenic considerations].
    Kamel D; Vaissman I; Veloso E; Rotman F; Manhães H
    Arq Bras Endocrinol Metabol; 1969 Dec; 18(3):163-84. PubMed ID: 4935190
    [No Abstract]   [Full Text] [Related]  

  • 19. Hypertension and dyslipidemia.
    Jazra C
    J Med Liban; 2000; 48(6):364-9. PubMed ID: 11503527
    [No Abstract]   [Full Text] [Related]  

  • 20. Hypertension: a new perspective in therapy and metabolic effect. Part I.
    Medina Ruiz A
    Bol Asoc Med P R; 1991 Sep; 83(9):399-401. PubMed ID: 1807274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.